Petros Pharmaceuticals, Inc. (PTPI) stock
PTPIOTCPharmaceutical PreparationsFiscal year ends December 31
$0.00+0.00 (+5.56%)
Close on Oct 19, 2026Market cap $135.07KP/E –Yield –
Petros Pharmaceuticals gross margin
Gross margin is gross profit as a percentage of revenue.
Petros Pharmaceuticals's gross margin for the twelve months ending Dec 31, 2024 was 76.3%. For fiscal 2024 it was 76.3%, against 72.0% the year before. The highest annual figure on record is 79.5% in fiscal 2021.
Annual gross margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | 76.3% | +4.3 |
| FY2023 | Dec 31, 2023 | 72.0% | +10.2 |
| FY2022 | Dec 31, 2022 | 61.8% | −17.7 |
| FY2021 | Dec 31, 2021 | 79.5% | +21.9 |
| FY2020 | Dec 31, 2020 | 57.7% | – |
Quarterly gross margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q4 FY2024 | Dec 31, 2024 | 63.5% | −12.1 |
| Q3 FY2024 | Sep 30, 2024 | 81.8% | +7.6 |
| Q2 FY2024 | Jun 30, 2024 | 76.8% | −1.3 |
| Q1 FY2024 | Mar 31, 2024 | 76.1% | +86.5 |
| Q3 FY2023 | Sep 30, 2023 | 75.6% | −8.9 |
| Q2 FY2023 | Jun 30, 2023 | 74.2% | −6.6 |
| Q1 FY2023 | Mar 31, 2023 | 78.1% | −5.9 |
| Q4 FY2022 | Dec 31, 2022 | -10.4% | −94.6 |
| Q2 FY2022 | Jun 30, 2022 | 84.5% | +43.9 |
| Q1 FY2022 | Mar 31, 2022 | 80.8% | +9.2 |
| Q2 FY2021 | Jun 30, 2021 | 84.0% | +23.3 |
| Q1 FY2021 | Mar 31, 2021 | 84.2% | +28.0 |
| Q4 FY2020 | Dec 31, 2020 | 40.6% | – |
| Q3 FY2020 | Sep 30, 2020 | 71.7% | – |
| Q2 FY2020 | Jun 30, 2020 | 60.7% | – |
| Q1 FY2020 | Mar 31, 2020 | 56.2% | – |
See a number that looks wrong?